What payment terms are accepted?

Accepted payment terms include T/T, LC, PayPal, and Western Union.

What is the lead time for production?

Lead time varies by season: within 15 workdays, one month, or 1-3 months for both peak and off-season.

High Efficiency Fluidized Bed Dry Machine

Name: High Efficiency Fluidized Bed Dry Machine
Brand: Shanghai Pharmaceutical Machinery Co., Ltd.
SKU: 753408495

Shanghai, ChinaShanghai Pharmaceutical Machinery Co., Ltd.

US$15,000.00

1 Piece

Product profile

After-sales Service

1 Year

Warranty

1 Year

Heating Mode

Convective

Model NO.

Material Status

Granule, Powder

Drying Medium

Air

Operation Pressure

Vacuum

Structure

Single Layer

Operational Method

Semi-Continuous

Type

Pulse

Name

High Efficiency Fluidized Bed Dry Machine

Transport Package

Plywood Box

Specification

Trademark

SPM

Origin

China

Key features

GMP Compliant Design: Round structure avoids dead corners; vacuum operation ensures simple cleaning and hygiene.

Fast and Uniform Drying: Fluidization state formed by stirring; drying time typically 20-30 minutes with uniform temperature.

Anti-Agglomeration System: Internal hopper stirrer prevents raw material agglomeration and flow channel formation.

Customizable Discharge: Discharging system can be designed according to specific customer requests.

Wide Capacity Range: Available in 9 models with container volumes from 12L to 1500L and capacity up to 750 Kg/h.

Company profile

Experienced TeamExhibition ExperienceImporters and ExportersLow MOQ

Shanghai Pharmaceutical Machinery Co., Ltd.

Shanghai, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 20 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤5.90h CertifiedTerms of Payment: T/T, LC, PayPal, etc.

AI-Powered supplier vetting

SummaryThe supplier is identified as a Shanghai-based combined trading company with listed pharmaceutical equipment products and machining-related facilities. It reports extensive customization, R&D activity with new products in the past year, export experience of 20 years, and exports representing 90% of total sales. After-sales support includes repair services and overseas agents or branches, but no overseas warehouse or showroom. Finished-product inspection instructions are reportedly available and uniformly followed. The supplier does not provide ODM services, lacks an available SDK, and does not provide OEM services for well-known brands. Evidence is insufficient to verify certifications, detailed financial credibility, production scale, or named customer cases.

After-Sales capabilityThe supplier reports repair as an overseas service offering and states that it can provide services through overseas agents or branches. However, it has no overseas warehouse or showroom, so the evidence supports some service access but not comprehensive overseas infrastructure.

R&D capabilityThe supplier reports R&D capability and states that it launched new products during the past year. It does not have an available SDK and does not provide ODM services, but these limitations do not negate the explicit evidence of recent product development.

Production capacityThe supplier lists machining centers, CNC and milling equipment, provides a broad pharmaceutical-equipment product range, and reports a finished-product inspection method with instructions that are uniformly followed. However, the supplied data does not quantify production capacity, output, or manufacturing ownership, so production strength is only partially evidenced.

Customization capabilityBoth R&D and design-service records explicitly list customization from samples, designs, full customization, minor customization, and flexible customization. This is direct evidence of a broad customization offering.